FDA Developing Documents on Critical-to-Quality Factors

The GMP Letter
A A
The FDA is aiming to develop additional documents and policies to help investigators and devicemakers understand Critical to Quality factors.

To View This Article:

Login

Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $40.00